Quercetin and Hydroxytyrosol Effects on NAFLD in a Liver-on-a-Chip Model

A liver-on-a-chip study investigates the effects of polyphenols Quercetin and Hydroxytyrosol on non-alcoholic fatty liver disease progression. The dataset likely contains results from high-content analysis of a 3D tissue microenvironment modeling human disease. The research was conducted by Manuele Gori from Università Campus Bio-Medico.

Use Cases

• Evaluate polyphenol efficacy against hepatic steatosis based on high-content analysis results
• Benchmark organ-on-a-chip performance against traditional 2D culture systems for disease modeling
• Study cytoprotective and antioxidant mechanisms of natural compounds in a pathological liver model
• Develop novel therapeutic strategies for NAFLD based on experimental insights from the chip model

Strengths

• Focuses on NAFLD, the most common form of chronic liver disease
• Uses a physiologically relevant 3D liver-on-a-chip model as described
• Tests two specific, naturally occurring polyphenols: Quercetin and Hydroxytyrosol

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Last update date is unknown; freshness unverified

Provenance

Source

paperswithcode

Collection Method

Experimental study using a liver-on-a-chip model and high-content analysis